by Lauran NeergaardIn this photo provided by the WVU Rockefeller Neuroscience Institute, an Alzheimer’s patient undergoes focused ultrasound treatment with the WVU RNI team in Morgantown, W.Va., on Oc
by Lauran NeergaardIn this photo provided by the WVU Rockefeller Neuroscience Institute, an Alzheimer’s patient undergoes focused ultrasound treatment with the WVU RNI team in Morgantown, W.Va., on Oc
by University of GuamResearchers process dried chips from the seeds of Guam's native cycad tree in preparation of foods for experimental mammal consumption. The status of knowledge about toxi
by University of GuamResearchers process dried chips from the seeds of Guam's native cycad tree in preparation of foods for experimental mammal consumption. The status of knowledge about toxi
byMassachusetts Institute of TechnologyA 3D rendering of a C. elegans worm, mapping all of its neurons. Credit: Steve Flavell/MIT Picower InstituteBecause serotonin is one of the primary chemica
byMassachusetts Institute of TechnologyA 3D rendering of a C. elegans worm, mapping all of its neurons. Credit: Steve Flavell/MIT Picower InstituteBecause serotonin is one of the primary chemica
(HealthDay)—Tauvid (flortaucipir F18), a radioactive diagnostic agent, was approved to image tau pathology in patients with cognitive impairment being evaluated for Alzheimer disease, the U.S. Food an
(HealthDay)—Tauvid (flortaucipir F18), a radioactive diagnostic agent, was approved to image tau pathology in patients with cognitive impairment being evaluated for Alzheimer disease, the U.S. Food an
by Medical Journal of AustraliaCredit: Unsplash/CC0 Public DomainAducanumab, a controversial Alzheimer's disease medication with "questionable efficacy," is under review by the Therapeut
by Medical Journal of AustraliaCredit: Unsplash/CC0 Public DomainAducanumab, a controversial Alzheimer's disease medication with "questionable efficacy," is under review by the Therapeut
by Suzanne Leigh,University of California, San FranciscoArtwork from a patient with semantic variant primary progressive aphasia. Credit: University of California, San FranciscoFor decades, doct
by Suzanne Leigh,University of California, San FranciscoArtwork from a patient with semantic variant primary progressive aphasia. Credit: University of California, San FranciscoFor decades, doct
by Valerie Goodwin,University of MichiganCredit: CC0 Public DomainFor patients with multiple sclerosis, a regular exercise routine is important for managing symptoms. But due to different causes
by Valerie Goodwin,University of MichiganCredit: CC0 Public DomainFor patients with multiple sclerosis, a regular exercise routine is important for managing symptoms. But due to different causes
by Dr Laura Glitsos,ParticleCredit: CC0 Public DomainWhile garlic breath might not be good for your social life, Curtin University researchers have found a certain garlic extract that may fight
by Dr Laura Glitsos,ParticleCredit: CC0 Public DomainWhile garlic breath might not be good for your social life, Curtin University researchers have found a certain garlic extract that may fight
byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainResearchers have for the first time identified degeneration-associated "molecular markers"—observable changes in
byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainResearchers have for the first time identified degeneration-associated "molecular markers"—observable changes in
byKeck School of Medicine of USCCredit: Pixabay/CC0 Public DomainIn a first for USC Stem Cell scientists, the laboratory of Giorgia Quadrato has pioneered a novel human brain organoid model that
byKeck School of Medicine of USCCredit: Pixabay/CC0 Public DomainIn a first for USC Stem Cell scientists, the laboratory of Giorgia Quadrato has pioneered a novel human brain organoid model that
by Diana Yates,University of Illinois at Urbana-ChampaignWhen tested in a mouse model of Alzheimer's disease, a new compound, L1, reduced neuroinflammation, amyloid plaques and other molecul
by Diana Yates,University of Illinois at Urbana-ChampaignWhen tested in a mouse model of Alzheimer's disease, a new compound, L1, reduced neuroinflammation, amyloid plaques and other molecul